180 related articles for article (PubMed ID: 25996654)
1. Atypical IgM multiple myeloma with deletion of c-MAF.
Juárez Salcedo LM; López Rubio M; Gil Fernández JJ; Garcia-Suarez J; Magro E; Arranz E; Gutiérrez Jomarrón I; Marcellini Antonio S; Blasco A; Burgaleta C
Int J Lab Hematol; 2015 Oct; 37(5):686-9. PubMed ID: 25996654
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.
Elba S; Castellino A; Soriasio R; Castellino C; Bonferroni M; Mattei D; Strola G; Drandi D; Mordini N; Foglietta M; Rapezzi D; Celeghini I; Grasso M; Giordano F; Fraternali Orcioni G; Massaia M
J Med Case Rep; 2020 Jun; 14(1):75. PubMed ID: 32564775
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Prognosis of MAF Deletion in Chinese Patients With Multiple Myeloma.
Wang Y; Li Q; Xing S; Zhang H; Li D
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e545-e550. PubMed ID: 31262667
[TBL] [Abstract][Full Text] [Related]
4. IgM myeloma and Waldenstrom's macroglobulinemia: a distinct clinical feature, histology, immunophenotype, and chromosomal abnormality.
Chehal A; Taher A; Shamseddine A
Clin Lab Haematol; 2003 Jun; 25(3):187-90. PubMed ID: 12755797
[TBL] [Abstract][Full Text] [Related]
5. IgM myeloma: a report of four cases.
Dierlamm T; Laack E; Dierlamm J; Fiedler W; Hossfeld DK
Ann Hematol; 2002 Mar; 81(3):136-9. PubMed ID: 11904738
[TBL] [Abstract][Full Text] [Related]
6. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
7. IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia.
Schuster SR; Rajkumar SV; Dispenzieri A; Morice W; Aspitia AM; Ansell S; Kyle R; Mikhael J
Am J Hematol; 2010 Nov; 85(11):853-5. PubMed ID: 20842638
[TBL] [Abstract][Full Text] [Related]
8. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
Bladé J; Montoto S; Rosiñol L; Montserrat E
Semin Oncol; 2003 Apr; 30(2):329-31. PubMed ID: 12720163
[TBL] [Abstract][Full Text] [Related]
9. [IgM myeloma: a report of 2 cases].
Masanés F; Pedrol E; Bladé J; Casademont J; de la Sierra A; Martínez-Orozco F; Grau JM; Ingelmo M
Med Clin (Barc); 1991 May; 96(20):777-9. PubMed ID: 1908542
[TBL] [Abstract][Full Text] [Related]
10. IgM multiple myeloma: report of four cases and review of the literature.
Annibali O; Petrucci MT; Del Bianco P; Gallucci C; Levi A; Foà R; Avvisati G
Leuk Lymphoma; 2006 Aug; 47(8):1565-9. PubMed ID: 16966268
[TBL] [Abstract][Full Text] [Related]
11. Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia.
Atrash S; Zhang Q; Papanikolaou X; Stein C; Abdallah AO; Barlogie B
J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241189
[TBL] [Abstract][Full Text] [Related]
12. IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma.
Donovan KA; Lacy MQ; Gertz MA; Lust JA
Leukemia; 2002 Mar; 16(3):382-5. PubMed ID: 11896542
[TBL] [Abstract][Full Text] [Related]
13. [Specific cutaneous localizations in multiple myeloma and Waldenström's macroglobulinemia. Apropos of 4 cases].
Fayol J; Bernard P; Bordessoule D; Vire O; Malinvaud G; Bonnetblanc JM
Ann Dermatol Venereol; 1985; 112(6-7):509-16. PubMed ID: 3935033
[TBL] [Abstract][Full Text] [Related]
14. IgM myeloma--its distinction from Waldenström's macroglobulinemia.
Takahashi K; Yamamura F; Motoyama H
Acta Pathol Jpn; 1986 Oct; 36(10):1553-63. PubMed ID: 3099541
[TBL] [Abstract][Full Text] [Related]
15. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
Bianchi G; Richardson PG; Anderson KC
J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
[TBL] [Abstract][Full Text] [Related]
16. Complete remission of Waldenström's associated generalized crystal-storing histiocytosis of IgM lambda subtype with bortezomib-based combination chemotherapy.
Baird SM; Kenealy MK; Hoy R
Leuk Lymphoma; 2015; 56(11):3233-5. PubMed ID: 25837422
[No Abstract] [Full Text] [Related]
17. IgM myeloma: case report with immunophenotypic profile.
Haghighi B; Yanagihara R; Cornbleet PJ
Am J Hematol; 1998 Dec; 59(4):302-8. PubMed ID: 9840911
[TBL] [Abstract][Full Text] [Related]
18. [IgM myeloma].
Roujeau JC; Bisson M; Segond P; Massias P
Sem Hop; 1976 Nov; 52(40):2277-82. PubMed ID: 188179
[TBL] [Abstract][Full Text] [Related]
19. [IgM myeloma: 6 cases and a review of the literature].
De Gramont A; Grosbois B; Michaux JL; Peny AM; Pollet JP; Smadja N; Krulik M; Debray J; Bernard JF; Monconduit M
Rev Med Interne; 1990; 11(1):13-8. PubMed ID: 2109345
[TBL] [Abstract][Full Text] [Related]
20. Case Report of IgM Multiple Myeloma: Diagnosing a Rare Hematologic Entity.
Bonilla-Valentín FJ; Cerra J; Cáceres-Perkins W; Alsina M
Cancer Control; 2018; 25(1):1073274817744448. PubMed ID: 29318955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
